Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-center Randomized Controlled Trial Comparing the Standard Method and Target-controlled Infusion as a Method of Administering Cefoxitin, Which is Used to Prevent Surgical Site Infections in Colorectal Surgical Patients

NCT05253339 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT05253339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05253339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-center Randomized Controlled Trial Comparing the Standard Method and Target-controlled Infusion as a Method of Administering Cefoxitin, Which is Used to Prevent Surgical Site Infections in Colorectal Surgical Patients
Lead sponsor
Asan Medical Center
Phase
Not applicable
Overall status
Completed
Start date
April 4, 2022
Completion date
August 28, 2025
Enrollment
2,494 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anti-bacterial agents, general surgery, pharmacokinetics